ArticlePharmacogenetics and genomics2016

CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: a case-control study.

Adolfo Figueiras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.